Lv4
418 积分 2026-01-06 加入
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function
17天前
已完结
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases
26天前
已完结
Safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of HRS‐1893, a cardiac myosin inhibitor, in healthy subjects
1个月前
已完结
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial
1个月前
已完结
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
1个月前
已完结
Farnesoid X Receptor-Mediated Bile Acids Regulation in Cholestasis
1个月前
已完结
FXR-targeted drug discovery: Recent advances and therapeutic perspectives
1个月前
已完结
Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis
1个月前
已完结
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
